100 related articles for article (PubMed ID: 22173253)
1. ACE gene sequence and nucleotide variants in IgA nephropathy.
Woo KT; Lau YK; Chan CM; Zhao Y; Tan HB; Liu FE; Fook-Chong S; Wong KS
Singapore Med J; 2011 Nov; 52(11):824-34. PubMed ID: 22173253
[TBL] [Abstract][Full Text] [Related]
2. Disease progression, response to ACEI/ATRA therapy and influence of ACE gene in IgA nephritis.
Woo KT; Lau YK; Zhao Y; Liu FE; Tan HB; Tan EK; Stephanie FC; Chan CM; Wong KS
Cell Mol Immunol; 2007 Jun; 4(3):227-32. PubMed ID: 17601378
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of renin-angiotensin system genes in IgA nephropathy.
Woo KT; Lau YK; Choong LH; Zhao Y; Tan HB; Fook-Chong S; Tan EK; Yap HK; Wong KS
Nephrology (Carlton); 2004 Oct; 9(5):304-9. PubMed ID: 15504143
[TBL] [Abstract][Full Text] [Related]
4. The renin--angiotensin system gene polymorphisms and clinicopathological correlations in IgA nephropathy.
Ong-Ajyooth S; Ong-Ajyooth L; Limmongkon A; Tiensingh A; Parichatikanon P; Nilwarangkur S
J Med Assoc Thai; 1999 Jul; 82(7):681-9. PubMed ID: 10511770
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis.
Woo KT; Lau YK; Chan CM; Wong KS
Ann Acad Med Singap; 2008 May; 37(5):372-6. PubMed ID: 18536822
[TBL] [Abstract][Full Text] [Related]
6. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme genotype and outcome in pediatric IgA nephropathy.
Santos NM; Ault BH; Gharavi AG; Kritchevsky SB; Quasney MW; Jackson EC; Fisher KA; Woodford SY; Mitchell BL; Gaber LW; Arheart KL; Wyatt RJ
Pediatr Nephrol; 2002 Jul; 17(7):496-502. PubMed ID: 12172761
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system gene polymorphisms: its impact on IgAN and its progression to end-stage renal failure among Chinese in Singapore.
Lau YK; Woo KT; Choong HL; Zhao Y; Tan HB; Chong SM; Tan EK; Yap HK; Wong KS
Nephron Physiol; 2004; 97(1):p1-8. PubMed ID: 15153745
[TBL] [Abstract][Full Text] [Related]
9. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients.
Zhou TB; Yin SS; Liang R
J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):235-41. PubMed ID: 23060471
[TBL] [Abstract][Full Text] [Related]
11. A synergistic association of ACE I/D and eNOS G894T gene variants with the progression of immunoglobulin A nephropathy - a pilot study.
Rodríguez-Pérez JC; Macías-Reyes A; Jiménez-Sosa A; Companioni O; Rodríguez-Esparragón FJ; Cobo MA; Checa-Andrés MD; Palop-Cubillo L; Alonso A; Torres A
Am J Nephrol; 2009; 30(3):303-9. PubMed ID: 19546528
[TBL] [Abstract][Full Text] [Related]
12. Correlation analysis of angiotensin-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase gene polymorphisms and the progression of immunoglobulin A nephropathy/membranous nephropathy.
Zhu X; Kong D; Zhang L; Sun Y; Na S; Han C; Jin X
Hum Pathol; 2013 Dec; 44(12):2806-13. PubMed ID: 24157068
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.
Vegter S; Perna A; Hiddema W; Ruggenenti P; Remuzzi G; Navis G; Postma MJ
Pharmacogenet Genomics; 2009 Sep; 19(9):695-703. PubMed ID: 19696696
[TBL] [Abstract][Full Text] [Related]
14. Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy.
Szelestei T; Bähring S; Kovács T; Vas T; Salamon C; Busjahn A; Luft FC; Nagy J
Am J Kidney Dis; 2000 Sep; 36(3):468-73. PubMed ID: 10977777
[TBL] [Abstract][Full Text] [Related]
15. [Association of single nucleotide polymorphism of megsin gene with IgA nephropathy].
Wang ZH; Chen N; Pan XX; Ren H; Wang WM; Zhang W; Hao CL; Zhu J; Lu Y; Han B
Zhonghua Yi Xue Za Zhi; 2006 May; 86(19):1337-41. PubMed ID: 16796905
[TBL] [Abstract][Full Text] [Related]
16. Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy.
Narita I; Goto S; Saito N; Song J; Omori K; Kondo D; Sakatsume M; Gejyo F
Kidney Int; 2003 Sep; 64(3):1050-8. PubMed ID: 12911556
[TBL] [Abstract][Full Text] [Related]
17. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with the clinico-pathological manifestations in immunoglobulin A nephropathy patients.
Chen X; Liu S; Ye Y; Xu Q
Chin Med J (Engl); 1997 Jul; 110(7):526-9. PubMed ID: 9594210
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme (ACE) haplotypes and cyclosporine A (CsA) response: a model of the complex relationship between ACE quantitative trait locus and pathological phenotypes.
Catarsi P; Ravazzolo R; Emma F; Fruci D; Finos L; Frau A; Morreale G; Carrea A; Ghiggeri GM
Hum Mol Genet; 2005 Aug; 14(16):2357-67. PubMed ID: 16002416
[TBL] [Abstract][Full Text] [Related]
19. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
Vleming LJ; van der Pijl JW; Lemkes HH; Westendorp RG; Maassen JA; Daha MR; van Es LA; van Kooten C
Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885
[TBL] [Abstract][Full Text] [Related]
20. Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients.
Narita I; Goto S; Saito N; Song J; Ajiro J; Sato F; Saga D; Kondo D; Akazawa K; Sakatsume M; Gejyo F
Hypertension; 2003 Sep; 42(3):304-9. PubMed ID: 12885793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
